Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Assets
Cash and due from financial institutions	$ 3,025	$ 3,131
Federal funds sold and cash equivalents	49,122	24,298
Total cash and cash equivalents	52,147	27,429
Investment securities available for sale, at fair value	37,880	42,567
Investment securities held to maturity (fair value of $2,515 at September 30, 2016 and $2,471 at December 31, 2015)	2,213	2,181
Total investment securities	40,093	44,748
Loans held for sale	0	2,640
Loans, net of unearned income	817,403	758,501
Less: Allowance for loan losses	(14,874)	(16,136)
Net loans	802,529	742,365
Accrued interest receivable	2,904	3,012
Premises and equipment, net	5,035	4,591
Other real estate owned (OREO)	10,635	16,629
Restricted stock, at cost	4,208	4,789
Bank owned life insurance (BOLI)	24,364	23,822
Deferred tax asset	10,606	10,928
Other assets	2,077	4,171
Total Assets	954,598	885,124
Deposits
Noninterest-bearing deposits	79,682	52,773
Interest-bearing deposits	660,194	612,437
Total deposits	739,876	665,210
FHLBNY borrowings	69,650	84,650
Subordinated debentures	13,403	13,403
Accrued interest payable	581	494
Other liabilities	5,891	9,160
Total liabilities	829,401	772,917
Equity
Preferred stock, 1,000,000 shares authorized, $1,000 liquidation value Series B - non-cumulative convertible; Issued: 20,000 shares at September 30, 2016 and December 31, 2015	20,000	20,000
Common stock, $.10 par value; authorized 15,000,000 shares; Issued: 6,843,159 shares at September 30, 2016 and 6,501,610 at December 31, 2015	713	650
Additional paid-in capital	62,094	53,984
Retained earnings	45,092	40,582
Accumulated other comprehensive income (loss)	318	(165)
Treasury stock, 284,522 shares at September 30, 2016 and 280,354 shares at December 31, 2015, at cost	(3,015)	(3,011)
Total shareholders’ equity	125,202	112,040
Noncontrolling interest in consolidated subsidiaries	(5)	167
Total equity	125,197	112,207
Total liabilities and equity	$ 954,598	$ 885,124